Thanh Nguyen, MD
Radiation Oncology · Weatherford, TXNPI 1023050069
Payments from drug & device makers
Across 43 payments — averaging $25.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$115
- Teleflex LLC$104
- AstraZeneca$81
- Tempus AI, Inc$70
- E.r. Squibb & Sons, L.L.C.$63
- Tactile Systems Technology Inc$56
- plus $586 from 22 others
What the payments were for
- Food & beverage$1,077100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 1 | $115 |
| Teleflex LLC | 1 | $104 |
| AstraZeneca | 4 | $81 |
| Tempus AI, Inc | 1 | $70 |
| E.r. Squibb & Sons, L.L.C. | 3 | $63 |
| Tactile Systems Technology Inc | 3 | $56 |
| Adaptive Biotechnologies Corporation | 3 | $56 |
| AbbVie | 3 | $52 |
| Foundation Medicine, Inc. | 1 | $45 |
| Genentech USA, Inc. | 2 | $44 |
| Incyte Corporation | 2 | $39 |
| Pharmaessentia USA Corporation | 1 | $32 |
| GSK | 2 | $29 |
| Amgen | 2 | $27 |
| Karyopharm Therapeutics Inc. | 1 | $25 |
| Caris MPI, Inc. | 1 | $22 |
| Exelixis Inc. | 1 | $21 |
| Sanofi | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Seagen Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Stemline Therapeutics Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Beone Medicines USA, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,077 in reported general payments places this provider in the 55th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 164 | $7,714 |
| Fentanyl | 50 | $4,771 |
| Tamsulosin Hcl | 90 | $1,409 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $987 |
| Gabapentin | 60 | $892 |
| Oxybutynin Chloride ErOxybutynin Chloride | 55 | $888 |
| Triamcinolone Acetonide | 119 | $842 |
| Lidocaine Hcl ViscousLidocaine Hcl | 39 | $620 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 20 | $609 |
| SsdSilver Sulfadiazine | 40 | $601 |
| Oxycodone Hcl | 15 | $523 |
| Dexamethasone | 18 | $498 |
| Hydromorphone Hcl | 12 | $394 |
| Pantoprazole Sodium | 50 | $388 |
| Prochlorperazine Maleate | 21 | $345 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Weatherford
- Daniel GomezHouston$8.7M
- Neil DesaiDallas$8.6M
- Chad TangHouston$7.7M
- James WelshHouston$5.1M
- Caroline ChungHouston$3.7M
- Karen HoffmanHouston$2.6M
- Clifton FullerHouston$1.6M
- Robert TimmermanDallas$1.5M
- Steven LinHouston$1.5M
- Chenyang WangHouston$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.